DK106145C - Fremgangsmåde til fremstilling af 4,1-benzoxazepin-2,5(1H,3H)-dioner. - Google Patents
Fremgangsmåde til fremstilling af 4,1-benzoxazepin-2,5(1H,3H)-dioner.Info
- Publication number
- DK106145C DK106145C DK168764AA DK168764A DK106145C DK 106145 C DK106145 C DK 106145C DK 168764A A DK168764A A DK 168764AA DK 168764 A DK168764 A DK 168764A DK 106145 C DK106145 C DK 106145C
- Authority
- DK
- Denmark
- Prior art keywords
- benzoxazepine
- diones
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/90—Oxygen atoms with acyclic radicals attached in position 2 or 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
- C07C243/24—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
- C07C243/38—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D267/02—Seven-membered rings
- C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D267/14—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US270786A US3214429A (en) | 1963-04-05 | 1963-04-05 | Quinazolinones and process for preparing |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK106145C true DK106145C (da) | 1966-12-27 |
Family
ID=23032799
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK168764AA DK106145C (da) | 1963-04-05 | 1964-04-06 | Fremgangsmåde til fremstilling af 4,1-benzoxazepin-2,5(1H,3H)-dioner. |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US3214429A (fr) |
| BE (3) | BE646086A (fr) |
| DK (1) | DK106145C (fr) |
| ES (3) | ES298318A1 (fr) |
| FR (1) | FR3294M (fr) |
| GB (3) | GB1016526A (fr) |
| NL (3) | NL6403406A (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3549636A (en) * | 1968-02-29 | 1970-12-22 | Pennwalt Corp | 2-alkanoyl,alkanoylalkyl,alkanoyloxyalkyl,and hydroxyalkyl substituted tetrahydro - halo - sulfamyl- quinazolinones |
| GB8823475D0 (en) * | 1988-10-06 | 1988-11-16 | Merck Sharp & Dohme | Chemical compounds |
| GB9310069D0 (en) * | 1993-05-17 | 1993-06-30 | Zeneca Ltd | Heterocyclic compounds |
-
1963
- 1963-04-05 US US270786A patent/US3214429A/en not_active Expired - Lifetime
-
1964
- 1964-03-26 GB GB12816/64A patent/GB1016526A/en not_active Expired
- 1964-03-26 GB GB12818/64A patent/GB1016527A/en not_active Expired
- 1964-03-26 GB GB12817/64A patent/GB1017264A/en not_active Expired
- 1964-03-28 FR FR969121A patent/FR3294M/fr active Active
- 1964-03-31 NL NL6403406A patent/NL6403406A/xx unknown
- 1964-03-31 NL NL6403404A patent/NL6403404A/xx unknown
- 1964-03-31 NL NL6403405A patent/NL6403405A/xx unknown
- 1964-04-03 BE BE646086D patent/BE646086A/xx unknown
- 1964-04-03 BE BE646084D patent/BE646084A/xx unknown
- 1964-04-03 BE BE646085D patent/BE646085A/xx unknown
- 1964-04-04 ES ES298318A patent/ES298318A1/es not_active Expired
- 1964-04-04 ES ES0298317A patent/ES298317A1/es not_active Expired
- 1964-04-04 ES ES298316A patent/ES298316A1/es not_active Expired
- 1964-04-06 DK DK168764AA patent/DK106145C/da active
Also Published As
| Publication number | Publication date |
|---|---|
| BE646085A (fr) | 1964-10-05 |
| ES298316A1 (es) | 1964-06-01 |
| FR3294M (fr) | 1965-05-03 |
| GB1017264A (en) | 1966-01-19 |
| NL6403405A (fr) | 1964-10-06 |
| US3214429A (en) | 1965-10-26 |
| NL6403404A (fr) | 1964-10-06 |
| BE646086A (fr) | 1964-10-05 |
| GB1016527A (en) | 1966-01-12 |
| ES298318A1 (es) | 1964-06-01 |
| GB1016526A (en) | 1966-01-12 |
| BE646084A (fr) | 1964-10-05 |
| NL6403406A (fr) | 1964-10-06 |
| ES298317A1 (es) | 1964-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK106552C (da) | Fremgangsmåde til fremstilling af substituerede 6,7-benzomorphaner. | |
| DK123984B (da) | Fremgangsmåde til fremstilling af styren-α-methylstyren-acrylonitril-copolymere. | |
| DK108500C (da) | Fremgangsmåde til fremstilling af 1-glykosyl-5-azacytosiner. | |
| DK117957B (da) | Fremgangsmåde til fremstilling af 13β-alkyl-3-oxogona-4,9,11-triener. | |
| DK111889B (da) | Fremgangsmåde til fremstilling af 3-N-substituerede tricycloundecaner. | |
| DK108072C (da) | Fremgangsmåde til fremstilling af substituerede 5-fluor-pyrimidinnucleosider. | |
| DK106185C (da) | Fremgangsmåde til fremstilling af 17α-acyloxy-4,6-pregnadien-20-oner. | |
| DK119107B (da) | Fremgangsmåde til fremstilling af 11β-hydroperoxy-3-oxo-13-alkyl-Δ<4,9>-gonadiener. | |
| DK104461C (da) | Fremgangsmåde til fremstilling af 3-amino-isoxazoler. | |
| DK106145C (da) | Fremgangsmåde til fremstilling af 4,1-benzoxazepin-2,5(1H,3H)-dioner. | |
| DK106328C (da) | Fremgangsmåde til fremstilling af 17α-alkoxy-16-methylen-3,20-diketopregnanderivater. | |
| DK105592C (da) | Fremgangsmåde til fremstilling af substituerede 5-fluor-pyrimidiner. | |
| DK107031C (da) | Fremgangsmåde til fremstilling af 2-halogenmethyl-quinazolin-3-oxider. | |
| DK114556B (da) | Fremgangsmåde til fremstilling af 1,4-benzodiazepin-2-on-4-oxider. | |
| DK116357B (da) | Fremgangsmåde til fremstilling af 1,1,1,2,2-pentafluor-3-chlorpropan. | |
| DK104571C (da) | Fremgangsmåde til fremstilling af trans-2-phenyl-3-methylmorpholin. | |
| DK106329C (da) | Fremgangsmåde til fremstilling af 3,20-dioxo-19-nor-4,9,11-pregnatrien. | |
| DK120131B (da) | Fremgangsmåde til fremstilling af 3-oxo-13β-alkylgona-4,9,11-triener. | |
| DK115622B (da) | Fremgangsmåde til fremstilling af 3-oxogona-4,9,11-triener. | |
| DK109895C (da) | Fremgangsmåde til fremstilling af 1,3-dioxo-2-alkyl-cyclopentaner. | |
| DK114904B (da) | Fremgangsmåde til fremstilling af 3,5-diiodthyroniner. | |
| DK116368B (da) | Fremgangsmåde til fremstilling af 2,3-dihydro-2,2,4-trimethyl-7-benzofuranol. | |
| DK109137C (da) | Fremgangsmåde til fremstilling af propionaldehyd. | |
| DK108153C (da) | Fremgangsmåde til fremstilling af 1-alkyl-5-nitroimidazol-2-carboxylater. | |
| DK105983C (da) | Fremgangsmåde til fremstilling af 2-alkoxy-5-aryl-3H-1,4-benzodiazepin-4-oxider. |